Recently, colleagues from ICON’s Social Responsibility Chapter proudly joined Fundación Nacel Arcoíris to support the conservation of the Presa Madín ecosystem in Mexico. 110 volunteers came together to maintain 20 tree...
-
ICON announces results of Annual General Meeting
ICON plc today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 31, 2026 were duly passed by shareholders.
-
ICON reports second quarter 2026 results
Quarter two revenue of $2,063.5 million, an increase of 1.4% on quarter one 2026.
-
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
ICON plc today announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON’s digital innovation and AI strategy, and builds on Orbis – ICON’s secure, governed, agentic AI platform.
-
ICON schedules second quarter 2026 earnings conference call
ICON will release its financial results for the second quarter 2026 after the market closes on Wednesday, July 29, 2026.
-
ICON reports first quarter 2026 results
Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025.
-
ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development
Advancing ICON’s previously announced plan to invest in digital innovation and AI over the next three years.
-
ICON schedules first quarter 2026 earnings conference call
ICON will release its financial results for the first quarter 2026 after the market closes on Tuesday, June 23, 2026.
-
ICON reports fourth quarter and full year 2025 results
ICON plc today reported its financial results for the fourth quarter and full year 2025, and announced the outcome of its investigation by the Audit Committee of the Board of Directors into certain accounting practices.
-
ICON expands US early phase research capabilities
ICON plc today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas.
-
ICON provides update on audit committee investigation and timing of fourth quarter and full year 2025 financial results
ICON plc today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company’s accounting practices and controls.
